NorthWest Biotherapeutics Inc (NWBO)

[DocLee]

Hygro, I honestly think that you really don't understand the basic premise behind medical research, especially when it comes to fatal disorders such as glioblastoma multiforme (GBM). With such conditions any treatment, either singly or in combination, which does not cure all cases will be considered as not "being effective enough" [my emphasis]. Any investigator worth his/her salt (eg Prof Liau) will see this as a challenge and will formulate ways of increasing the effectiveness of the treatment until it is 100% effective. That is what the SPORE trials and the many other dendrocytic trials are doing. It does not indicate that the treatment doesn't work - only that it should be improved, and that is what is being done.

As money seems to be your underlying motive, your assessment of NWBO as becoming a "zombie biotech company" is laughable. In addition to producing DCVax which kills tumour cells without side effects, NWBO has developed the "foot in the door" which allows other treatments to gain access to the malignant cells and increase the effectiveness of the treatment. DCVax is proving itself to be the vital component of a potential cure for 100% of glioblastomas (and probably all solid tumours). Without it the other treatments are as nothing - GBM will continue as 100% fatal in a relatively short time. DCVax is the one component that is absolutely necessary for combinations of adjunct treatments to work as they were designed to work and it will continue to be the vital component until superseded by the next treatment paradigm (whatever that might be).

To put your fiscally orientated mind at rest, NWBO will not become a Zombie anything since it has assured its own immunity from that condition by patenting everything about the production process that is patentable. Irrespective of the profits from treatments that NWBO might produce and market under its own label, and irrespective of the royalties from treatments it licences out to other companies, patent fees from other entities using the DCVax methods will, at the very least, produce an adequate source of money to stop it becoming a financial zombie.

2026 is looking rosier each day.